PHASE-I TRIAL OF DIPYRIDAMOLE WITH 5-FLUOROURACIL AND FOLINIC ACID

被引：0
|
作者：
BUDD, GT
JAYARAJ, A
GRABOWSKI, D
ADELSTEIN, D
BAUER, L
BOYETT, J
BUKOWSKI, R
MURTHY, S
WEICK, J
机构：
[1] CLEVELAND CLIN FDN,CLEVELAND,OH 44195
[2] BOEHRINGER INGLEHEIM PHARMACEUT,RIDGEFIELD,CT
来源：
CANCER RESEARCH | 1990年 / 50卷 / 22期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：7206 / 7211
页数：6
相关论文
共 50 条
  • [41] ENHANCEMENT OF THE ANTITUMOR EFFECTS OF 5-FLUOROURACIL BY FOLINIC ACID
    MINI, E
    TRAVE, F
    RUSTUM, YM
    BERTINO, JR
    PHARMACOLOGY & THERAPEUTICS, 1990, 47 (01) : 1 - 19
  • [42] BIOCHEMICAL MODULATION OF 5-FLUOROURACIL WITH BREQUINAR - RESULTS OF A PHASE-I STUDY
    BUZAID, AC
    PIZZORNO, G
    MARSH, JC
    RAVIKUMAR, TS
    MURREN, JR
    TODD, M
    STRAIR, RK
    POO, WJ
    HAIT, WN
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1995, 36 (05) : 373 - 378
  • [43] FOLINIC ACID EFFECT ON 5-FLUOROURACIL KINETICS INVIVO
    HERRMANN, R
    REUTER, J
    PORT, R
    OSSWALD, H
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1988, 114 (01) : 87 - 90
  • [44] PHASE-I TRIAL OF COMBINATION CHEMOTHERAPY USING 5-FLUOROURACIL (5-FU) AND ICRF-159
    PAUL, AR
    ENGSTROM, PF
    BELLET, RE
    CATALANO, RB
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1977, 18 (MAR): : 284 - 284
  • [45] 5-fluorouracil plus folinic acid with or without ifosfamide in advanced colorectal cancer: A phase II randomized trial
    Sdrobolini, A
    Contu, A
    Massidda, B
    Gasperoni, S
    Recchia, F
    Iannelli, A
    Tomao, S
    Romiti, A
    Raffaele, M
    Ortu, S
    Campisi, C
    Gebbia, V
    Olmeo, N
    Ionta, MT
    Angiona, S
    Di Costanzo, F
    TUMORI, 2000, 86 (03) : 211 - 214
  • [46] Paclitaxel, 5-fluorouracil, and folinic acid in metastatic breast cancer: BRE-26, a phase II trial
    Johnson, DH
    Paul, D
    Hande, KR
    SEMINARS IN ONCOLOGY, 1997, 24 (01) : S22 - S25
  • [47] Phase I study of gemcitabine in combination with cisplatin, 5-fluorouracil and folinic acid in patients with advanced esophageal cancer
    Oettle, H
    Arnold, D
    Kern, M
    Hoepffner, N
    Settmacher, U
    Neuhaus, P
    Riess, H
    ANTI-CANCER DRUGS, 2002, 13 (08) : 833 - 838
  • [48] 5-fluorouracil versus folinic acid and 5-fluorouracil in advanced, hormone-resistant prostate cancer: A prospective, randomized pilot trial
    Breul, J
    Jakse, G
    Forster, G
    Lampel, A
    Rohani, A
    Hartung, R
    EUROPEAN UROLOGY, 1997, 32 (03) : 280 - 283
  • [49] Comparison of a 48-hour infusion of 5-fluorouracil without folinic acid with 24-hour folinic acid/5-fluorouracil in patients with metastatic colorectal cancer refractory to bolus folinic acid/5-fluorouracil - A prospective cohort study
    Moehler, M
    Gutzler, F
    Steinmann, S
    Boehme, M
    Raeth, U
    Stremmel, W
    Galle, PR
    Rudi, J
    CHEMOTHERAPY, 2003, 49 (1-2) : 85 - 89
  • [50] CONTINUOUS-INFUSION OF 5-FLUOROURACIL BY DOUBLE ROUTE (INTRAVENOUS AND INTRAPERITONEAL) WITH MODULATION BY FOLINIC ACID - CLINICAL AND PHARMACOKINETIC, PHASE-I STUDY IN PATIENTS WITH INTRAABDOMINAL MALIGNANCIES
    DEFORNI, M
    GUALANO, V
    CANAL, P
    MARTEL, P
    IZARSOUM, F
    CHEVREAU, C
    SOULIE, P
    ROCHE, H
    BUGAT, R
    BULLETIN DU CANCER, 1993, 80 (05) : 408 - 417
12345